SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Monsanto (MON) : Valuation and Ethics of BioEngineering
MON 127.950.0%Jun 8 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: richardred1/6/2007 1:22:21 AM
  Read Replies (1) of 40
 
Monsanto Sees Tremendous Progress in R & D Pipeline

St. Louis, MO -- Monsanto Company (NYSE:MON) reported on a remarkable year in research-and-development (R&D) advancements, highlighting progress across both its biotechnology and breeding platforms.

The company's announcement came as part of its first-quarter 2007 fiscal year conference call.

Monsanto reported on seven specific projects in the research-and- development pipeline that either advanced from one phase to the next or were added to the pipeline.

The update also highlighted the company's three High Impact Technology (HIT) projects.

"In the last two years, there has been positive movement in 70 percent of the projects in the pipeline," said Robert T. Fraley, Ph.D., chief technology officer and executive vice president for Monsanto.

"Of that advancement, almost half are from additions to the pipeline, reflecting the strength of our discovery engine and our collaborative efforts."

The presentation outlined several key measures of progress including the three HIT projects:

-- Roundup RReady2Yield soybeans, the company's next-generation, herbicide-tolerant technology in soybeans, moved to Phase 4. The movement, which was based on results from its 2006 breeding trials, advanced the technology one step closer to commercial launch.

-- Vistive III soybeans, designed to have a similar oil profile to olive oil, met the company's target composition profile on three of its genetic events.

-- First-generation Drought Tolerant corn continued to demonstrate yield benefits in its third year of field testing.

Other highlighted projects:

-- Second-generation Drought Tolerant corn continued to complement the first-generation trait, with strong performance in both water-stressed and broad-acre field testing.

-- Higher-Yielding corn advanced to Phase 2, with three of the company's genetic events demonstrating a five percent to ten percent yield increase.

-- Nitrogen Utilization corn technology events continued to demonstrate efficient use of nitrogen within testing environments, providing overall yield stability even as the amount of applied nitrogen decreased.

-- High-Oil soybeans, a soybean project from Monsanto's Renessen joint venture with Cargill, advanced to Phase 3 after the technology continued to demonstrate a clear oil yield advantage compared with conventional checks.

Breeding a Better Seed

Fraley's presentation was focused on the combined benefits of biotechnology and breeding, emphasizing the fact that both platforms drive plant science innovation.

"As excited as we are about the biotech pipeline, we understand that our success rides on the combination of biotechnology and breeding," Fraley said.

"We've put a lot of emphasis on making sure that -- before we ever look to biotechnology -- we have the best, highest yielding seed possible so farmers can start each season strong."

Backed by the company's breeding prowess, Monsanto's national seed brands continue to offer farmers higher-yielding seeds, Fraley noted.

In 2006, the yield advantage in Monsanto's national corn brands was reinforced through more than 49,000 corn breeding comparisons, which highlighted a record 11.7 bushels per acre advantage for Monsanto's DEKALB brand in the widely planted 110-day corn.

In soybeans, Fraley also highlighted a strategy that combines strong, conventional soy breeding capabilities with breakthrough applications of molecular breeding to more efficiently identify characteristics that are important to growers.

For more information, call Sara Duncan, Monsanto, at 314-694-2729.
grainnet.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext